# Cavco Industries, Inc.: financial statements, quarterly CVCO · Nasdaq · CIK 278166 · [Materials](/sectors/materials.md) · fiscal year ends Mar 28 Pages: [Overview](/companies/cvco.md) · [Financials](/companies/cvco/financials.md) · [Filings](/companies/cvco/filings.md) · [Insiders](/companies/cvco/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cvco/financials.md?period=annual). ## Income statement | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | Q4 FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q4 FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q4 FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [452](/filings/0000278166-24-000152.md) | [447](/filings/0000278166-25-000007.md) | [420 d](/filings/0001628280-26-037782.md) | [478](/filings/0000278166-25-000128.md) | [507](/filings/0001628280-25-047849.md) | [522](/filings/0001628280-26-004426.md) | [508 d](/filings/0001628280-26-037782.md) | [557](/filings/0001628280-26-051421.md) | [557](/filings/0001628280-25-047849.md) | [581](/filings/0001628280-26-004426.md) | [550 d](/filings/0001628280-26-037782.md) | [610](/filings/0001628280-26-051421.md) | | Cost of revenue | $m | [345](/filings/0000278166-24-000152.md) | [344](/filings/0000278166-25-000007.md) | [321 d](/filings/0000278166-24-000059.md) | [374](/filings/0000278166-24-000122.md) | [391](/filings/0000278166-24-000152.md) | [392](/filings/0000278166-25-000007.md) | [392 d](/filings/0001628280-26-037782.md) | [427](/filings/0001628280-26-051421.md) | [422](/filings/0001628280-25-047849.md) | [445](/filings/0001628280-26-004426.md) | [423 d](/filings/0001628280-26-037782.md) | [475](/filings/0001628280-26-051421.md) | | Gross profit | $m | [107](/filings/0000278166-24-000152.md) | [103](/filings/0000278166-25-000007.md) | [99.0 d](/filings/0001628280-26-037782.md) | [103](/filings/0000278166-25-000128.md) | [116](/filings/0001628280-25-047849.md) | [130](/filings/0001628280-26-004426.md) | [116 d](/filings/0001628280-26-037782.md) | [130](/filings/0001628280-26-051421.md) | [134](/filings/0001628280-25-047849.md) | [136](/filings/0001628280-26-004426.md) | [127 d](/filings/0001628280-26-037782.md) | [135](/filings/0001628280-26-051421.md) | | Selling, general and administrative | $m | [61.5](/filings/0000278166-24-000152.md) | [63.3](/filings/0000278166-25-000007.md) | [61.4 d](/filings/0001628280-26-037782.md) | [64.9](/filings/0000278166-25-000128.md) | [67.0](/filings/0001628280-25-047849.md) | [66.0](/filings/0001628280-26-004426.md) | [77.5 d](/filings/0001628280-26-037782.md) | [69.1](/filings/0001628280-26-051421.md) | [72.2](/filings/0001628280-25-047849.md) | [81.4](/filings/0001628280-26-004426.md) | [75.6 d](/filings/0001628280-26-037782.md) | [81.8](/filings/0001628280-26-051421.md) | | Operating income | $m | [45.5](/filings/0000278166-24-000152.md) | [39.7](/filings/0000278166-25-000007.md) | [37.6 d](/filings/0001628280-26-037782.md) | [38.6](/filings/0000278166-25-000128.md) | [49.1](/filings/0001628280-25-047849.md) | [64.0](/filings/0001628280-26-004426.md) | [38.6 d](/filings/0001628280-26-037782.md) | [60.4](/filings/0001628280-26-051421.md) | [62.2](/filings/0001628280-25-047849.md) | [54.6](/filings/0001628280-26-004426.md) | [51.5 d](/filings/0001628280-26-037782.md) | [52.8](/filings/0001628280-26-051421.md) | | Interest expense | $m | [0.3](/filings/0000278166-23-000083.md) | [0.8](/filings/0000278166-24-000007.md) | [0.3 d](/filings/0000278166-24-000059.md) | [0.1](/filings/0000278166-25-000128.md) | [0.1](/filings/0001628280-25-047849.md) | [0.2](/filings/0001628280-26-004426.md) | [0.1 d](/filings/0001628280-26-037782.md) | [0.2](/filings/0001628280-26-051421.md) | [0.1](/filings/0001628280-25-047849.md) | [0.1](/filings/0001628280-26-004426.md) | [0.1 d](/filings/0001628280-26-037782.md) | [0.1](/filings/0001628280-26-051421.md) | | Income tax | $m | [10.1](/filings/0000278166-24-000152.md) | [7.9](/filings/0000278166-25-000007.md) | [9.0 d](/filings/0001628280-26-037782.md) | [9.4](/filings/0000278166-25-000128.md) | [11.1](/filings/0001628280-25-047849.md) | [12.9](/filings/0001628280-26-004426.md) | [6.6 d](/filings/0001628280-26-037782.md) | [13.7](/filings/0001628280-26-051421.md) | [14.9](/filings/0001628280-25-047849.md) | [13.5](/filings/0001628280-26-004426.md) | [12.1 d](/filings/0001628280-26-037782.md) | [13.5](/filings/0001628280-26-051421.md) | | Net income | $m | [41.5](/filings/0000278166-24-000152.md) | [36.0](/filings/0000278166-25-000007.md) | [33.9 d](/filings/0001628280-26-037782.md) | [34.4](/filings/0001628280-26-004426.md) | [43.8](/filings/0001628280-26-004426.md) | [56.5](/filings/0001628280-26-004426.md) | [36.3 d](/filings/0001628280-26-037782.md) | [51.6](/filings/0001628280-26-051421.md) | [52.4](/filings/0001628280-26-004426.md) | [44.1](/filings/0001628280-26-004426.md) | [42.5 d](/filings/0001628280-26-037782.md) | [42.3](/filings/0001628280-26-051421.md) | | Diluted EPS | $ per share | [4.76](/filings/0000278166-24-000152.md) | [4.27](/filings/0000278166-25-000007.md) | not reported | [4.11](/filings/0000278166-25-000128.md) | [5.28](/filings/0001628280-25-047849.md) | [6.90](/filings/0001628280-26-004426.md) | not reported | [6.42](/filings/0001628280-26-051421.md) | [6.55](/filings/0001628280-25-047849.md) | [5.58](/filings/0001628280-26-004426.md) | not reported | [5.43](/filings/0001628280-26-051421.md) | | Basic EPS | $ per share | [4.80](/filings/0000278166-24-000152.md) | [4.31](/filings/0000278166-25-000007.md) | not reported | [4.15](/filings/0000278166-25-000128.md) | [5.33](/filings/0001628280-25-047849.md) | [6.97](/filings/0001628280-26-004426.md) | not reported | [6.49](/filings/0001628280-26-051421.md) | [6.62](/filings/0001628280-25-047849.md) | [5.65](/filings/0001628280-26-004426.md) | not reported | [5.48](/filings/0001628280-26-051421.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [377](/filings/0000278166-23-000083.md) | [353](/filings/0000278166-24-000007.md) | [353](/filings/0001628280-26-037782.md) | [359](/filings/0000278166-24-000122.md) | [364](/filings/0001628280-25-047849.md) | [363](/filings/0001628280-26-004426.md) | [356](/filings/0001628280-26-037782.md) | [345](/filings/0000278166-25-000128.md) | [375](/filings/0001628280-25-047849.md) | [225](/filings/0001628280-26-004426.md) | [237](/filings/0001628280-26-051421.md) | [243](/filings/0001628280-26-051421.md) | | Current assets | $m | [875](/filings/0000278166-23-000083.md) | [833](/filings/0000278166-24-000007.md) | [852](/filings/0000278166-25-000057.md) | [878](/filings/0000278166-24-000122.md) | [902](/filings/0000278166-24-000152.md) | [878](/filings/0000278166-25-000007.md) | [910](/filings/0001628280-26-037782.md) | [915](/filings/0000278166-25-000128.md) | [935](/filings/0001628280-25-047849.md) | [817](/filings/0001628280-26-004426.md) | [825](/filings/0001628280-26-051421.md) | [837](/filings/0001628280-26-051421.md) | | Total assets | $m | [1,369](/filings/0000278166-23-000083.md) | [1,327](/filings/0000278166-24-000007.md) | [1,354](/filings/0000278166-25-000057.md) | [1,381](/filings/0000278166-24-000122.md) | [1,398](/filings/0000278166-24-000152.md) | [1,386](/filings/0000278166-25-000007.md) | [1,407](/filings/0001628280-26-037782.md) | [1,420](/filings/0000278166-25-000128.md) | [1,449](/filings/0001628280-25-047849.md) | [1,472](/filings/0001628280-26-004426.md) | [1,491](/filings/0001628280-26-051421.md) | [1,541](/filings/0001628280-26-051421.md) | | Current liabilities | $m | [305](/filings/0000278166-23-000083.md) | [271](/filings/0000278166-24-000007.md) | [273](/filings/0000278166-25-000057.md) | [296](/filings/0000278166-24-000122.md) | [311](/filings/0000278166-24-000152.md) | [285](/filings/0000278166-25-000007.md) | [303](/filings/0001628280-26-037782.md) | [317](/filings/0000278166-25-000128.md) | [318](/filings/0001628280-25-047849.md) | [329](/filings/0001628280-26-004426.md) | [335](/filings/0001628280-26-051421.md) | [376](/filings/0001628280-26-051421.md) | | Total liabilities | $m | not reported | not reported | [321](/filings/0000278166-25-000057.md) | not reported | not reported | not reported | [342](/filings/0001628280-26-037782.md) | [355](/filings/0000278166-25-000128.md) | [363](/filings/0001628280-25-047849.md) | [383](/filings/0001628280-26-004426.md) | [388](/filings/0001628280-26-051421.md) | [431](/filings/0001628280-26-051421.md) | | Shareholders' equity | $m | [1,019](/filings/0000278166-25-000007.md) | [1,009](/filings/0000278166-25-000007.md) | [1,033](/filings/0001628280-26-037782.md) | [1,039](/filings/0001628280-26-004426.md) | [1,042](/filings/0001628280-26-004426.md) | [1,057](/filings/0001628280-26-004426.md) | [1,065](/filings/0001628280-26-051421.md) | [1,065](/filings/0001628280-26-051421.md) | [1,086](/filings/0001628280-26-004426.md) | [1,089](/filings/0001628280-26-004426.md) | [1,103](/filings/0001628280-26-051421.md) | [1,110](/filings/0001628280-26-051421.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | Q4 FY2024 (2024-03-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q4 FY2025 (2025-03-29) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q4 FY2026 (2026-03-28) | Q1 FY2027 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [77.9 d](/filings/0000278166-24-000152.md) | [45.9 d](/filings/0000278166-25-000007.md) | [18.6 d](/filings/0001628280-26-037782.md) | [47.4](/filings/0000278166-25-000128.md) | [54.7 d](/filings/0001628280-25-047849.md) | [37.8 d](/filings/0001628280-26-004426.md) | [38.6 d](/filings/0001628280-26-037782.md) | [55.5](/filings/0001628280-26-051421.md) | [78.5 d](/filings/0001628280-25-047849.md) | [66.1 d](/filings/0001628280-26-004426.md) | [67.4 d](/filings/0001628280-26-037782.md) | [74.5](/filings/0001628280-26-051421.md) | | Capital expenditure | $m | [4.3 d](/filings/0000278166-24-000152.md) | [4.8 d](/filings/0000278166-25-000007.md) | [4.2 d](/filings/0001628280-26-037782.md) | [5.0](/filings/0000278166-25-000128.md) | [4.9 d](/filings/0001628280-25-047849.md) | [5.4 d](/filings/0001628280-26-004426.md) | [6.1 d](/filings/0001628280-26-037782.md) | [9.1](/filings/0001628280-26-051421.md) | [9.7 d](/filings/0001628280-25-047849.md) | [8.5 d](/filings/0001628280-26-004426.md) | [8.0 d](/filings/0001628280-26-037782.md) | [25.5](/filings/0001628280-26-051421.md) | | Share repurchases | $m | [40.9 d](/filings/0000278166-24-000152.md) | [55.9 d](/filings/0000278166-25-000007.md) | [12.5 d](/filings/0001628280-26-037782.md) | [29.5](/filings/0000278166-25-000128.md) | [42.8 d](/filings/0001628280-25-047849.md) | [42.2 d](/filings/0001628280-26-004426.md) | [34.2 d](/filings/0001628280-26-037782.md) | [50.0](/filings/0001628280-26-051421.md) | [36.1 d](/filings/0001628280-25-047849.md) | [43.8 d](/filings/0001628280-26-004426.md) | [30.0 d](/filings/0001628280-26-037782.md) | [30.0](/filings/0001628280-26-051421.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q2 FY2023 (2022-10-01) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-07-01) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-30) | Q1 FY2025 (2024-06-29) | Q2 FY2025 (2024-09-28) | Q3 FY2025 (2024-12-28) | Q1 FY2026 (2025-06-28) | Q2 FY2026 (2025-09-27) | Q3 FY2026 (2025-12-27) | Q1 FY2027 (2026-06-27) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | thousands of shares | [8,979](/filings/0000278166-23-000083.md) | [8,936](/filings/0000278166-24-000007.md) | [8,758](/filings/0000278166-24-000122.md) | [8,731](/filings/0000278166-24-000152.md) | [8,432](/filings/0000278166-25-000007.md) | [8,372](/filings/0000278166-25-000128.md) | [8,305](/filings/0001628280-25-047849.md) | [8,187](/filings/0001628280-26-004426.md) | [8,041](/filings/0001628280-26-051421.md) | [7,993](/filings/0001628280-25-047849.md) | [7,891](/filings/0001628280-26-004426.md) | [7,784](/filings/0001628280-26-051421.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 7,689,402 at 2026-07-23, from the cover of the [10-Q filed 2026-07-31](/filings/0001628280-26-051421.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.